Telmisartan is a highly selective AT1- receptor antagonist approved for treatment of hypertension.
On the other hand,
telmisartan acts as a partial agonist on the nuclear peroxisome proliferator-activated receptor-γ that has been reported to exert anti-oxidative and anti-inflammatory effects (Benson et al.,2004).